Clinical Trial Update: Oral Immunotherapy for Peanut Allergy (PMIT) [Phase 2]

View source ↗

Summary

Phase 2 trial update on PMIT oral immunotherapy for peanut allergy; trial completed and results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• PMIT (Oral Immunotherapy for Peanut Allergy)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Food Hypersensitivity | Phase 2 | Status: COMPLETED | Results posted: 2017-05-03